COVID-19 epidemiological research in inflammatory bowel diseases (IBD), adults and children, which will include even asymptomatic positives (not feasible in Brazil), with the aim of monitoring and reporting outcomes that occur in these patients who use immunosuppressants and immunobiologicals as treatment of IBD

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    University of São Paulo
  • Principal Investigator

    N/A

  • Research Location

    Brazil
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease susceptibility

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Drug usersSex workers

  • Occupations of Interest

    Unspecified

Abstract